Genetic misdiagnoses and the potential for health disparities

New England Journal of Medicine

Volumn 375, Issue 7, 2016, Pages 655-665

  Manrai, Arjun K ^a,g   Funke, Birgit H ^c,d,h   Rehm, Heidi L ^e,h   Olesen, Morten S ⁱ   Maron, Bradley A ^b,f   Szolovits, Peter ^e   Margulies, David M ^j   Loscalzo, Joseph ^b   Kohane, Isaac S ^a,g  

^a Harvard Medical School Center for Biomedical Informatics   (United States)

^b Amgen Massachusetts   (United States)

^c Departments of Medicinal Chemistry   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e Department of Pathology ^*  (United States)

^f Division of Comparative Medicine Massachusetts Lnstitute of Technology   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h LABORATORY FOR MOLECULAR MEDICINE   (United States)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^j Rigshospitalet   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN; AFRICAN AMERICAN; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ERROR; EUROPEAN AMERICAN; EXOME; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HEALTH DISPARITY; HUMAN; HUMAN GENOME; HYPERTROPHIC CARDIOMYOPATHY; JPH2 GENE; MIDDLE AGED; MYBPC3 GENE; OBSCN GENE; PRIORITY JOURNAL; SCHOOL CHILD; TNNI3 GENE; TNNT2 GENE; YOUNG ADULT; ASIAN AMERICAN; CAUCASIAN; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOTYPE; HISPANIC; LABORATORY DIAGNOSIS; MUTATION; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ASIAN AMERICANS; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXOME; FALSE POSITIVE REACTIONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; GENOTYPE; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; MUTATION; SEQUENCE ANALYSIS, DNA; UNITED STATES; YOUNG ADULT;

EID: 84982187833     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1507092     Document Type: Article

References (42)

1. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287: 1308-20.
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 1995; 92: 785-9.
3. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013; 381: 242-55.
4. Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol 2012; 60: 705-15.
5. Weidemann F, Niemann M, Breunig F, et al. Long- Term effects of enzyme replacement therapy on Fabry cardiomyopathy: Evidence for a better outcome with early treatment. Circulation 2009; 119: 524-9.
6. Richards CS, Bale S, Bellissimo DB, et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med 2008; 10: 294-300.
7. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-24.
8. Rehm HL. Disease- Targeted sequencing: A cornerstone in the clinic. Nat Rev Genet 2013; 14: 295-300.
9. Duzkale H, Shen J, McLaughlin H, et al. A systematic approach to assessing the clinical significance of genetic variants. Clin Genet 2013; 84: 453-63.
10. Norton N, Robertson PD, Rieder MJ, et al. Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ Cardiovasc Genet 2012; 5: 167-74.
11. MacArthur DG, Balasubramanian S, Frankish A, et al. A systematic survey of loss-of-function variants in human proteincoding genes. Science 2012; 335: 823-8.
12. NHLBI GO Exome Sequencing Project (ESP). Exome variant server (http://evs.gs.washington.edu/EVS/).
13. Andreasen C, Nielsen JB, Refsgaard L, et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy- Associated genetic variants. Eur J Hum Genet 2013; 21: 918-28.
14. Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database: 2008 update. Genome Med 2009; 1: 13.
15. The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012; 491: 56-65.
16. Li JZ, Absher DM, Tang H, et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science 2008; 319: 1100-4.
17. Alfares AA, Kelly MA, McDermott G, et al. Results of clinical genetic testing of 2, 912 probands with hypertrophic cardiomyopathy: Expanded panels offer limited additional sensitivity. Genet Med 2015; 17: 880-8.
18. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308- 11.
19. Pickrell JK, Coop G, Novembre J, et al. Signals of recent positive selection in a worldwide sample of human populations. Genome Res 2009; 19: 826-37.
20. Ihaka R, Gentleman R. R: A language for data analysis and graphics. J Comput Graph Stat 1996; 5: 299-314.
21. Garcia-Castro M, Reguero JR, Batalla A, et al. Hypertrophic cardiomyopathy: low frequency of mutations in the betamyosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients. Clin Chem 2003; 49: 1279-85.
22. Arimura T, Matsumoto Y, Okazaki O, et al. Structural analysis of obscurin gene in hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2007; 362: 281-7.
23. Niimura H, Patton KK, McKenna WJ, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002; 105: 446-51.
24. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107: 2227-32.
25. Matsushita Y, Furukawa T, Kasanuki H, et al. Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy. J Hum Genet 2007; 52: 543-8.
26. Exome Aggregation Consortium (ExAC). ExAC browser (beta). 2016 (http://exac.broadinstitute.org).
27. Maron BJ, Yeates L, Semsarian C. Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy. Am J Cardiol 2011; 107: 604-8.
28. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359: 211-8.
29. Keinan A, Clark AG. Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 2012; 336: 740-3.
30. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.
31. Seldin MF, Pasaniuc B, Price AL. New approaches to disease mapping in admixed populations. Nat Rev Genet 2011; 12: 523-8.
32. Pugh TJ, Kelly MA, Gowrisankar S, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 2014; 16: 601-8.
33. Bick AG, Flannick J, Ito K, et al. Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. Am J Hum Genet 2012; 91: 513-9.
34. Morita H, Rehm HL, Menesses A, et al. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 2008; 358: 1899-908.
35. Ioannidis JPA, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004; 36: 1312-8.
36. Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014; 42 (Database issue): D980-5.
37. Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: National Academies Press, 2011.
38. Manrai AK, Ioannidis JPA, Kohane IS. Clinical genomics: from pathogenicity claims to quantitative risk estimates. JAMA 2016; 315: 1233-4.
39. Lo B. Sharing clinical trial data: maximizing benefits, minimizing risk. JAMA 2015; 313: 793-4.
40. Drazen JM. Sharing individual patient data from clinical trials. N Engl J Med 2015; 372: 201-2.
41. Wilcox AR, Neri PM, Volk LA, et al. A novel clinician interface to improve clinician access to up- To-date genetic results. J Am Med Inform Assoc 2014; 21(e1): E117- 21.
42. Klitzman R, Chung W, Marder K, et al. Attitudes and practices among internists concerning genetic testing. J Genet Couns 2013; 22: 90-100.